Not provided
Not provided
Not provided
| ID | Type | Description | Link |
|---|---|---|---|
| RTGX02 |
Not provided
Not provided
Low recruitement rate
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Class |
|---|---|
| Sorin Group France SAS | UNKNOWN |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Primary objective is to assess the efficacy of the new ATP Autoswitch function in simple, dual or triple chamber ICD.
The efficacy rate of the ATP Auto-switch function, defined as the % of VT episodes successfully reduced, will be compared with 85%.
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Paradym VR, DR and CRT models |
Not provided
| Measure | Description | Time Frame |
|---|---|---|
| Ventricular Tachyarrhythmia episode | % of VT episode successfully reduced by the ATP Auto-switch | 2 years |
| Measure | Description | Time Frame |
|---|---|---|
| Arrhythmia incidence | DEvice based data | 2 years |
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
ICD/CRT-D implanted patients population
Not provided
| Name | Affiliation | Role |
|---|---|---|
| SAVOURE Arnaud, MD | CHU Rouen | Principal Investigator |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| CHU Brest | Brest | France |
Not provided
Not provided
Not provided
Not provided